ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,855
Screening encounters
4,541
Diagnostic referrals
866
Outstanding pathways
311

Screening pathway

  1. Screening4,541Encounters
  2. Positive finding1,570Documented findings
  3. Referral866Diagnostic referrals
  4. Follow-up1,030Diagnostic visits
  5. Outcome555Resolved pathways

Stage totals use different units. Pending pathways: 311. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1002 · EXP-1002Synthetic · Site A

Full participant history through 2026-11-22, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · Invalid HPV result · Inadequate
  3. · Repeat plan · HPV DNA · Inadequate result · Scheduled for 2026-01-30
  4. · Screening · HPV DNA · Repeat · Inadequate result
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2027-02-13

Referral-time risk

No matching referral was available at this observation date.

Screened participants

3855 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1359 · Expanded synthetic participant 1359Site C — Rural Outreach Programme
EXP-1360 · Expanded synthetic participant 1360Site D — Community Engagement Programme
EXP-1361 · Expanded synthetic participant 1361Site A — Urban Referral Hub
EXP-1362 · Expanded synthetic participant 1362Site A — Urban Referral Hub
EXP-1363 · Expanded synthetic participant 1363Site B — Peri-Urban Access Programme
EXP-1364 · Expanded synthetic participant 1364Site D — Community Engagement Programme
EXP-1365 · Expanded synthetic participant 1365Site D — Community Engagement Programme
EXP-1366 · Expanded synthetic participant 1366Site C — Rural Outreach Programme
EXP-1367 · Expanded synthetic participant 1367Site C — Rural Outreach Programme
EXP-1368 · Expanded synthetic participant 1368Site C — Rural Outreach Programme
EXP-1370 · Expanded synthetic participant 1370Site E — Resource-Constrained Navigation Programme
EXP-1371 · Expanded synthetic participant 1371Site A — Urban Referral Hub
EXP-1372 · Expanded synthetic participant 1372Site E — Resource-Constrained Navigation Programme
EXP-1373 · Expanded synthetic participant 1373Site E — Resource-Constrained Navigation Programme
EXP-1375 · Expanded synthetic participant 1375Site B — Peri-Urban Access Programme
EXP-1376 · Expanded synthetic participant 1376Site C — Rural Outreach Programme
EXP-1377 · Expanded synthetic participant 1377Site B — Peri-Urban Access Programme
EXP-1378 · Expanded synthetic participant 1378Site B — Peri-Urban Access Programme
EXP-1379 · Expanded synthetic participant 1379Site C — Rural Outreach Programme
EXP-1380 · Expanded synthetic participant 1380Site C — Rural Outreach Programme
EXP-1381 · Expanded synthetic participant 1381Site B — Peri-Urban Access Programme
EXP-1382 · Expanded synthetic participant 1382Site D — Community Engagement Programme
EXP-1384 · Expanded synthetic participant 1384Site B — Peri-Urban Access Programme
EXP-1386 · Expanded synthetic participant 1386Site A — Urban Referral Hub
EXP-1389 · Expanded synthetic participant 1389Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1736
HPV DNA
2166
Cytology
639

Navigation activity

Barrier documented
768
Contact attempt
1272
Navigation intervention
333
Diagnostic booking
1081
Diagnostic visit
1030

Documented barriers

Contact difficulty
247
Transport difficulty
253
Appointment coordination
268

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.